Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £111.90m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Senior Appointments

22 Jun 2010 07:00

RNS Number : 9692N
Merchant Securities PLC
22 June 2010
 



AIM: MERC

22 June 2010

MERCHANT SECURITIES PLC

("Merchant Securities" or "the Group")

Senior Appointments

Merchant Securities, the financial services group, is pleased to announce two key senior appointments. Lindsay Mair will join the Group's securities business as Head of UK Small Cap Sales & Research and Chris Smith has been appointed as a Senior Executive to establish a research capability in the Financials sector. Both Lindsay Mair and Chris Smith join in September this year.

Lindsay Mair has over 20 years' experience of working within the UK Small/Mid Cap sector. Most recently, he was managing director of Astaire Securities plc. From 2004 to 2009, Lindsay was head of corporate finance at Daniel Stewart & Company plc, where he helped grow its corporate finance business. Prior to this, he worked in advisory and other roles at Corporate Synergy, Sheppards and Citicorp Scrimgeour Vickers. Lindsay qualified as a chartered accountant with Touche Ross in 1986.

Chris Smith has extensive experience as a financials analyst, covering pan-European financial stocks. Latterly, Chris was the senior financials analyst at Jefferies International Limited, having been general financials analyst at Oriel Securities Limited. Chris spent his early career at Barclays de Zoete Wedd Limited as part of the top ranked UK financials team and also worked for HSBC James Capel, where he was the top ranked speciality financials analyst.

These appointments follow the recent enlargement of the Group's institutional equity sales team, with Suzanne Johnson-Walsh joining the sales desk to work alongside head of sales, John Coulson. Suzanne has over 20 years' experience in the UK Smaller Companies market and equity sales. 

Commenting on the appointments, Chief Executive of Merchant Securities, Patrick Claridge, said,

"We have ambitions to develop our institutional sales and research capabilities and these appointments represent an encouraging step forward towards this goal. I am confident that the skills and experience which Lindsay and Chris bring will prove valuable in accelerating the growth of our offering and building our market share." 

For further information, please contact:

 

   

Merchant Securities plc

Patrick Claridge, Chief Executive

  T: 020 7375 9022
     
Arden Partners plc

Richard Day

Matthew Armitt

 

  T: 020 7614 5917
Biddicks

Katie Tzouliadis/Sophie Lane

  T: 020 7448 1000

 

 

About Merchant Securities plc

Based in London, Merchant Securities plc provides a broad range of financial services to private clients, institutions and companies. Specific services include private client investment and wealth management, institutional sales, research and trading, corporate finance and corporate broking.

 

The Group's principal subsidiary, Merchant John East Securities Limited, is authorised and regulated by the Financial Services Authority, a member of the London Stock Exchange and an approved Nominated Adviser to AIM companies.

 

Website: www.merchantjohneast.com 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPGUAGQUPUGCG
Date   Source Headline
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 202511:56 amRNSTR-1: Notification of Major Holdings
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSInterim Results
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSInvestor Presentation
18th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSNotice of Interim Results
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSBoard Appointment
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 202512:06 pmRNSResult of AGM and Directorate Change
25th Sep 20257:00 amRNSAGM Statement
17th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.